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Proteomic analysis of alternative splicing<p>Stably expre sed alternatively-spl ced protein isoforms are produced on a genome-wide scale in Drosophila.</p>
Abstract
Background: Alternative splicing of messenger RNA permits the formation of a wide range of
mature RNA transcripts and has the potential to generate a diverse spectrum of functional
proteins. Although there is extensive evidence for large scale alternative splicing at the transcript
level, there have been no comparable studies demonstrating the existence of alternatively spliced
protein isoforms.
Results: Recent advances in proteomics technology have allowed us to carry out a comprehensive
identification of protein isoforms in Drosophila. The analysis of this proteomic data confirmed the
presence of multiple alternative gene products for over a hundred Drosophila genes.
Conclusions: We demonstrate that proteomics techniques can detect the expression of stable
alternative splice isoforms on a genome-wide scale. Many of these alternative isoforms are likely to
have regions that are disordered in solution, and specific proteomics methodologies may be
required to identify these peptides.
Background
The alternative splicing of pre-messenger RNA (mRNA)
allows for the generation of diverse mature RNA transcripts
from a single mRNA strand [1,2]. Recent studies have esti-
mated that more than 60% of multi-exon human genes [3-5]
and at least 40% of Drosophila genes [6] can produce differ-
ently spliced mRNA transcripts. The extent of alternative
splicing of transcripts has led to suggestions that its purpose
is to expand functional complexity in the cell [7,8] and that
alternative splicing may be one of the keys to understanding
the discrepancy between the number of genes and functional
complexity [9]. Alternative splicing events within protein
coding regions can generate a range of protein isoforms with
altered structure and biological function [10-12] and, there-
fore, alternative splicing has the potential to expand the cellu-
lar protein repertoire. However, there is still some
controversy about the degree of impact that individual alter-
native splicing events can have in vivo on the range of conven-
tional protein functions [11,13].
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Considerable supporting evidence exists for the expression of
multiple alternative mRNA transcripts. The expression of
many differently spliced mRNA transcripts is strongly sup-
ported by both microarray data [4] and by cDNA and
expressed sequence tag (EST) sequence evidence [3]. There is
overwhelming evidence for the expression of transcripts even
when these might encode protein sequences with unusual
evolutionary or structural features, but it is much more diffi-
cult to demonstrate the existence of alternative variants at the
protein level. To date, most evidence for the translation of
alternative splice variants as stable proteins has come from
individual experiments. One well known example is the
Dscam gene, which codes for an axon guidance receptor
involved in the formation of synaptic branching patterns in
neural circuit development [14]. It has four sets of mutually
exclusive alternative exons that code for three immunoglobu-
lin-like domains and a trans-membrane domain that could
theoretically generate 38,016 different protein isoforms. It
has been shown that the expression of different Dscam iso-
forms affects the recognition of mechanosensory neurons [15]
and two Dscam isoforms have been crystallized [16]. Another
important example in Drosophila is the Sex lethal gene.
Alternative splicing of this gene determines whether the fly
will be male or female [17]. Sex lethal encodes an RNA-bind-
ing protein that forms part of a complex regulatory cascade
[18]. The male-specific isoform of Sex lethal is an inactive
truncated protein.
Incontrovertible evidence for the expression of alternative
protein variants ought to be available from proteomics tech-
nologies, but until recently these methods have only been able
to identify a fraction of the peptide ions present in protease
(tryptic) digests. This has hindered the analysis of protein iso-
forms. However, one recent study was able to show that 16
pairs of alternative protein isoforms were expressed in
humans [19] based on peptide data from the Peptide Atlas
[20]. Two recent large scale proteomics studies have gener-
ated extensive, high quality peptide catalogs from the Dro-
sophila melangaster proteome. The first was able to match
peptides to almost 7,000 proteins (50% of the Drosophila
genome), a level of coverage that has not been reached for any
other complex eukaryote [21]. It was achieved using a novel
iterative strategy that maximized sample diversity. The sec-
ond study detected phosphorylated peptides representing
3,500 Drosophila proteins [22]. The two studies are comple-
mentary; only a fraction of the peptides detected were present
in both studies. Both studies also used the same protein data-
base to assign peptide sequences to the generated tandem
mass spectra, facilitating the comparison of the two datasets.
The extent and coverage of these two sets of peptides has
allowed us to perform the first large-scale analysis of alterna-
tive splicing at the protein level. This analysis demonstrates
that the expression of protein isoforms is widespread and
points the way towards further research in this area. The
results presented here should prompt further studies to gen-
erate and analyze proteomic data sets in the search for protein
isoforms expressed in different organisms.
Results and discussion
Our analysis was based on the peptides detected in two pro-
teomics studies [21,22]. The 'Brunner set' consisted of 32,729
non-overlapping peptides from the D. melangaster proteome
[21]. The 'Bodenmiller set' contained 10,118 high-confidence
phosphorylated peptides [22]. There were significant differ-
ences in the collection methods. In the Brunner analysis the
protein samples came from experiments carried out under a
wide range of distinct conditions and developmental stages of
Drosophila, while the samples used in the Bodenmiller anal-
ysis were from a single Drosophila cell line grown under just
five different conditions. In both studies the peptides were
identified by searching against in silico trypsin digests of the
FlyBase D. melangaster proteome [23].
Identifying splice isoform unique peptides
In the first step of analysis we searched for peptides that
unambiguously indicated the presence of two or more splice
isoforms from the same gene from the more than 42,000 pep-
tides identified in the two proteomics studies. Peptides were
matched to the proteins in FlyBase (release 5.4). Since Fly-
Base was used to identify the peptides from both studies, the
peptides could be mapped back directly to proteins in FlyBase
using a simple Perl script. Each of the more than 42,000 pep-
tides mapped to at least one gene in FlyBase.
FlyBase release 5.4 contains 15,181 genes, of which 14,141 are
predicted to be protein coding. The release contains a total of
20,823 protein coding transcripts and 17,961 of the polypep-
tide gene products are unique. The 2,762 transcripts that are
alternatively spliced in the 3' or 5' untranslatable regions were
not considered in this study, since they produce identical
translated products and cannot be distinguished with peptide
data alone. A total of 2,406 protein-coding genes (17.01%)
code for more than one gene product.
It is important to note that the peptides in the Brunner and
Bodenmiller experiments were identified using FlyBase. This
means that neither of the studies could characterize peptides
that did not match FlyBase sequences. As a result, our analy-
sis of splice isoforms had to be limited to the alternative splice
isoforms annotated in FlyBase. Therefore, the highest possi-
ble detectable alternative splicing rate from the two experi-
ments was 17.01%.
After matching the Brunner and Bodenmiller peptides to the
unique proteins in FlyBase, we searched for genes that had
two or more alternative isoforms confirmed by the peptide
evidence. Genes with confirmed alternative protein isoforms
were those for which it was possible to map peptides to
regions unique to two or more alternative isoforms. In other
words, where the detected peptides could unequivocally dem-
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onstrate the presence of two gene products with distinct pro-
tein sequences (for example, Figure 1).
The peptide evidence from the Brunner set confirmed multi-
ple alternative isoforms for 76 genes and the evidence from
the Bodenmiller set confirmed multiple alternative isoforms
for 60 genes. There was a certain amount of overlap between
the two experiments - 19 genes had multiple isoforms con-
firmed by the peptides from both analyses. In addition, when
the two sets of peptides were combined there was evidence for
alternative gene products from another 13 genes. In total, we
were able to demonstrate that 130 separate Drosophila genes
expressed at least two alternative isoforms (Additional data
file 1). While this is only a small proportion of the genes that
are supposed to express alternative protein isoforms, the fig-
ure is considerably higher than any previous study we know.
Those genes for which it was possible to show the presence of
three or more distinct gene products were particularly inter-
esting. Five genes - SNF4A-gamma, Akap200, 14-3-3-epsi-
lon, mod(mdg4), and LOLA - each expressed at least four
distinct gene products. By combining the peptide data it was
possible to show that one gene, LOLA, expressed at least
seven different isoforms (Figure 1). The 26 splice isoforms of
LOLA annotated in Flybase have very different carboxyl ter-
mini, but two-thirds of them include two zinc-finger domains.
All seven confirmed LOLA splice isoforms have both carboxy-
terminal zinc-finger domains (Figure 2). Of the five genes
shown to have more than two distinct gene products, there
are individual studies for LOLA [24], SNF4A-gamma [25]
and mod(mdg4) [26] that predict the presence of multiple
splice isoforms.
There was no evidence of the expression of alternative splice
isoforms of the Dscam protein that was mentioned in the
introduction, but the two studies did show the expression of
different isoforms of Sex lethal (for the tandem mass spectra
of the phosphopeptides for the two isoforms see Additional
data files 2-4). Other genes that are predicted to have differ-
ently functioning splice isoforms include CTBP, thought to be
important in development and to have two variants that are
conserved across all insect species [27], Eif2 and Su(var)3-9,
which fuse in Drosophila and are expected to create two dif-
ferent gene products [28], and Polychaetoid [29] and Thiore-
doxin reductase [30], both of which are predicted to have
gene products whose cellular locations are controlled by
alternative splicing.
Simulated peptide detection
While the two studies present irrefutable evidence that alter-
natively spliced transcripts are expressed as proteins, the
total number of genes with confirmed alternative products
from the two experiments is small. We could confirm the
expression of alternative protein isoforms for just 1.1% of the
6,980 unambiguously identified genes in the Brunner set,
Schematic representation of the LOLA geneFigure 1
Schematic representation of the LOLA gene. The figure shows a representation of the seven variants detected by the two analyses. Coding exons are 
shown in shades of gray and the position of the BTB and zinc-finger domains are marked in color. Introns are not to scale. LOLA variants have an invariant 
amino-terminal region, but different carboxyl termini. Despite the differences, all these carboxy-terminal regions contain paired zinc-finger domains. 
Peptides detected for this gene are shown as vertical dashed lines, and are highlighted in orange when the peptide crosses the exon boundary. All the 
peptides detected in the two analyses were in the variable carboxy-terminal regions.
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while the Bodenmiller study showed that 1.8% of the 3,472
identified genes express more than one protein isoform.
However, this apparently low level of alternative splicing at
the protein level has to be seen in the context of the relatively
low coverage of the Drosophila proteome by the two experi-
ments. Although the peptides detected by the Brunner study
did confirm the presence of gene products for more than half
of the Drosophila genes, the identified peptides covered just
5% of the amino acid residues in the Drosophila proteome.
This obviously decreases the chances of finding peptides that
unambiguously correspond to alternatively spliced regions.
In order to demonstrate whether the low rates of detection of
alternative isoforms are significant, we carried out simulated
in silico peptide identification experiments. These in silico
experiments determine the expected rates of detection
assuming that all peptides are equally detectable, even
though some proteins may be more abundant or more easily
detectable than others. The simulations cannot tell us what
the real rate of alternative splicing at the protein level is, since
the maximum detectable rate is limited by the rate of alterna-
tive splicing found in FlyBase (in this particular case 17%; see
above). However, they do provide an estimation of the
number of alternative isoforms that we would have expected
the two experiments to detect.
For the comparison with the Brunner analysis we drew 37,279
peptides at random from an in silico trypsin digest of the D.
melangaster proteome based on Flybase release 5.4. The sim-
ulation was performed 1,000 times. The results showed that a
random selection of 37,279 peptides from the in silico digest
would be expected to confirm the expression of alternatively
spliced isoforms for a mean of 242.75 genes (standard devia-
tion of 9.23). By way of contrast, the peptides identified in the
Brunner analysis confirmed multiple alternatively spliced
isoforms for just 76 genes.
For the Bodenmiller study we drew 10,118 peptides at random
from the in silico trypsin digest and again the simulation was
performed 1,000 times. From the random drawing we were
able to show that 10,118 peptides would be expected to con-
firm expression of distinct splice isoforms for a mean of 56.24
genes (standard deviation of 5.05). The Bodenmiller analysis
confirmed multiple alternatively spliced gene products for 60
genes.
The simulations allowed us to show that the Brunner analysis
detects a little under a third of the number of genes that would
be expected to produce alternative isoforms. There are several
possible explanations for this. One reason may be that many
isoforms are only expressed in certain tissues or certain
stages of development. Given the wide range of cell types and
developmental states that were used in this experiment, this
explanation seems less likely. A second possibility is that the
transcripts predicted from cDNA and EST evidence are sim-
ply not all transcribed and the transcript evidence is an over-
estimation of the real number of proteins expressed in the
cell. Another explanation might be that many alternative iso-
forms may only be expressed in very low quantities and are
less easily detected.
By way of contrast with the results from the Brunner simula-
tions, the 60 genes with confirmed multiple alternatively
spliced gene products in the Bodenmiller analysis is almost
exactly what would be expected from the Bodenmiller simu-
lations. It is somewhat surprising that it was the Bodenmiller
analysis, and not the Brunner analysis, that detected the rate
of alternative splicing expected from the random simulations.
The prevailing ideology of alternative splicing assumes that
alternative isoforms are expressed in distinct tissues and
developmental stages; therefore, we would expect to confirm
a higher rate of alternative splicing with the Brunner analysis,
where many cell types and developmental stages were inter-
Alignment of LOLA isoformsFigure 2
Alignment of LOLA isoforms. The alignment of the carboxy-terminal C2H2 DNA-binding zinc finger domains of the seven detected LOLA isoforms 
(CG12052). Six isoforms have two C2H2 zinc-finger domains, isoform PP has a C2H2 DNA-binding zinc-finger domain and a C2HC zinc finger domain. Zinc-
binding residues (cysteines and histidines) are marked in red, and structurally important residues marked in green. The symbols below the alignment 
indicate the degree of conservation of the aligned residues: asterisk, completely conserved column; colon, highly conserved column; single dot, some 
conservation.
CG12052-PB      DNGAGHPCPVCGRVYKLKSSLRNHQKWEC-GKEPQFQCPF-CVYRAKQKMHIGRHMERMHKEKFK
CG12052-PG      DGEPVYECRHCGKKYRWKSTLRRHENVECGGKEPSHQCPY-CPYKSKQRGNLGVHVRKHHTDLPQ
CG12052-PI      DPESRYVCRHCGKKYRWKSTLRRHENVECGGKEPCHPCPY-CSYKAKQRGNLGVHVRKHHPEKPQ
CG12052-PJ      --GGAYACDRCGNTYARPHSLNRHVRFEC-GVEPKFECPI-CHKKSKHKHNLVLHMR-THQHR--
CG12052-PO      SRDSFMQCKHCNRYYKSHQKLQEHVRKYC-LKQKKYKCVS-CEYRSRRKDHVLRHAKRKHCMLYE
CG12052-PQ      AASAPFVCQTCGRRYQVLGTLRRHMRKEC-NQPKKYVCRM-CERRFHYNFKLQDHYYYVHKGVQK
CG12052-PP      DIEKPWVCRNCNRTYKWKNSLKCHLKNEC-GLPPRYFCSKMCGYATNVHSNLKRHLNTKCRDREK
                       *  *.. *    .*. * .  *      . *   *    . . ::  *    :
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rogated, than in the Bodenmiller analysis, where only a single
cell type was tested.
The difference in the frequency of alternative splicing
detected by the two studies is enlightening. The Bodenmiller
analysis identified proportionally more alternative isoforms
than the Brunner analysis (1.8% of genes detected in the Bod-
enmiller study had alternative protein isoforms, compared to
1.1% detected in the Brunner experiments) and this is even
more clear from the simulations. The contrasting results from
the two analyses strongly suggest the possibility that methods
such as those used in the Bodenmiller analysis are more sen-
sitive when it comes to detecting certain alternative isoforms.
While some peptides were identified by both studies, on the
whole the peptides recognized by the two analyses are differ-
ent. This is clear from the residue composition of the peptides
detected by the two analyses. Although the residue composi-
tion of the peptides found in the Brunner analysis is similar to
the residue composition of the Drosophila proteome - except
that there are fewer basic residues and more acidic residues
(Figure 3b) - the peptides detected in the Bodenmiller analy-
sis have a quite distinctive composition (Figure 3a). The Bod-
enmiller analysis specifically selected peptides that were
phosphorylated. The peptides detected in these experiments
have substantially more serine residues (unsurprising
because almost 90% of the phosphorylated residues are ser-
ines), but also many more proline (5.5-7.6%), asparagine
(4.7-5.7%), glycine (6.2-7.2%) and aspartate residues (5.2-
5.9%). All these values are significantly higher than expected
according to Chi-squared tests (p-values < 0.005).
In addition, all hydrophobic residues are markedly under-
represented: the values for cysteine (1.83% of the residues in
the Drosophila proteome and just 0.63% of the Bodenmiller
peptides), phenylalanine (3.47 and 2.18%), isoleucine (4.9
and 3.71%), leucine (8.94 and 6.69%), methionine (2.33 and
1.14%), valine (5.9 and 5.34%), tryptophan (0.98 and 0.35%)
and tyrosine (2.92 and 1.57%) are significantly less than
expected (all Chi-squared p-values < 0.005). The peptides
from the Bodenmiller set are considerably less hydrophobic
than normal - just one in five of the Bodenmiller residues are
hydrophobic, compared to the one in three residues in the
Drosophila proteome (Figure 3c).
This residue composition of the Bodenmiller peptides is typi-
cal of regions that are disordered in solution. It is well known
that proteins with few hydrophobic residues and more polar
residues are likely to correspond to disordered regions of the
structure [31,32]. Studies also suggest that phosphorylated
residues tend to be more frequent in flexible, unstructured
segments and linkers [33,34]. Taken together, this informa-
tion strongly suggests that many of the Bodenmiller peptides,
as well as being in exposed regions on the surface of proteins,
will be disordered when in solution. Indeed, where the Bod-
enmiller peptides can be mapped to known structures, most
map to regions on the surface or regions known to be disor-
dered in solution (Figure 4).
False positive rates
It is widely recognized that a certain proportion of peptides
identified in proteomics techniques can be false positives.
However, both the Brunner and Bodenmiller studies have low
rates of false positives. The Brunner analysis has a false posi-
tive rate of approximately 5% and the Bodenmiller analysis
has a false positive rate of 1-4%. Even if 10% of these peptides
were to be false positives (twice the determined value), there
would still be considerably more than 100 genes with evi-
dence of alternative splicing at the protein level from the two
studies. In any case, a small number of false positives will not
affect the main conclusions of this study. Most alternative
transcripts do seem to produce alternative gene products and
many of these alternative isoforms may have regions that are
disordered in solution.
Re-analysis of the spectra
Given the depth and range of peptides detected in the two
studies, we might also have expected to be able to uncover the
expression of peptides not in FlyBase, such as those from pre-
dicted genes and transcripts (isoforms), translated pseudo-
genes and small RNAs, or in principal any other peptide
produced by the 6-frame translation of the fly genome. A
complete re-analysis of the spectra from the Bodenmiller
study was beyond the scope of this paper, but we were able to
carry out an initial re-analysis against a locally generated
database that contained 903,842 peptides from translated
transcripts from predicted gene models, translated pseudo-
genes and translated miscellaneous functional RNA. The re-
analysis identified seven peptides that mapped exclusively to
predicted gene models and two peptides that were linked to
the miscellaneous RNA. There was no evidence for the
expression of any of the pseudogenes as peptides.
Three of the predicted gene models (genscan_masked:gene2
54366, genscan_masked:gene247065, and genscan_masked:
gene245985) were not similar to any sequences in the Uni-
Prot database. One ab initio predicted gene model
(genscan_masked:gene264127) did match a unique sequence
in UniProt, but only because the prediction itself had been
erroneously included in the UniProt sequence database.
One peptide mapped to four different predictions
(genscan_masked:gene266459, genie_masked:gene170301
0, genie_masked:gene1402427 and genscan_masked:gene13
91762) that were 40% identical to a putative gag-pol protein
(Drosophila ananassae). The remaining two predicted gene
models identified by the spectra might be alternative variants
of vav (both genie_masked:gene1736185 and genscan_mask
ed:gene267148) and lethal (2) 05510 (genscan_masked:
gene263593) but have yet to be annotated as variants in Fly-
Base.
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Composition of peptides identified in the Brunner and Bodenmiller studiesFigure 3
Composition of peptides identified in the Brunner and Bodenmiller studies. FlyBase residue composition was calculated from Flybase release 5.4. (a) 
Comparison of the percentage of each amino acid found in the Bodenmiller peptides and in the Drosophila proteome. (b) Comparison of the proportion of 
each amino acid in the Brunner peptides and the Drosophila proteome. The three sets of proteins differed most in the proportion of hydrophobic and 
disorder-promoting residues. (c) Comparison of the percentage of each type of residue in five different sets of peptides. Hydrophobic residues were C, F, 
I, L, M, V, W and Y. Disorder promoting residues (Extreme LDR) were A, D, E, G, P, N and S (according to Romero et al. [35]). BodenDisc is the subset 
of peptides that could be used to discriminate one isoform from another in the Bodenmiller analysis; BrunnDisc is the subset of peptides that could be 
used to discriminate one isoform from another in the Brunner analysis. The Brunner discriminating peptides had markedly fewer hydrophobic residues and 
markedly more disorder promoting residues than the whole set of Brunner peptides and the Drosophila proteome.
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Of the two miscellaneous transcripts identified by the re-
analysis of the spectra, one is a piece of rRNA (FBtr0114214)
that is not similar to anything in the UniProt database and the
other maps to a piece of small nucleolar RNA (snoRNA; Or-
aca1, FBtr0113530) that, when translated, is 71% identical
(but over just 20 residues) to the hypothetical protein
SNOG_09564 (Phaeosphaeria nodorum SN15). Or-aca1 is
located inside an intron of ribosomal protein S16.
Conclusion
Genome-wide expression of alternative isoforms
We have been able to demonstrate conclusive evidence for the
genome-wide expression of alternative splice variants at the
protein level and have shown that distinct proteins are indeed
produced from alternative splice variants. The results from
the two large-scale proteomics studies on which our analysis
is based showed that the expression of alternative gene prod-
Mapping of detected phosphorylation sites to known structuresFigure 4
Mapping of detected phosphorylation sites to known structures. Peptides detected in the Bodenmiller analysis were mapped to highly similar, known 
structures. The three-dimensional structures are shown in orange spacefilling representation except where the peptides map to the structures (shown as 
black ribbons). Detected phosphorylation sites are shown as black dots. (a) The alternative isoforms generated from shaggy are 76% sequence identical to 
human glycogen synthase kinase 3 beta [PDB:1j1c]. The peptides detected in the analysis covered two regions. The amino-terminal region includes 22 
residues that are known to be disordered in solution and are therefore not shown. (b) The structure for Drosophila fructose-1-biphosphate aldolase has 
been solved and the Bodenmiller analysis finds peptides covering two regions - both are on the surface of the structure. (c) Drosophila moesin has 75% 
identity to fall army worm moesin, for which the three-dimensional structure has been solved [PDB:2i1j]; in addition to the residues marked as found in 
the Bodenmiller analysis, a further 15 residues that were detected are not shown in the figure because they are disordered in solution. (d) The isoforms 
generated from alphabet are 52% identical to human phosphatase 2C [PDB:1a6q]. The analysis detected two peptides, one of which also coincided with the 
14 disordered carboxy-terminal residues of the template (not shown).
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ucts is extensive. These studies confirmed the presence of
multiple alternative isoforms for over a hundred genes. More-
over, the alternative isoforms detected in these two studies
were sufficiently stable in vivo and produced in sufficient
quantities to be detectable in proteomics workflows. Even
though the current technical limitations of proteomics stud-
ies allowed the recovery of just a small fraction of the poten-
tial alternative isoforms (less than 2% of Drosophila genes
were identified with alternative protein isoforms), the results
were enough to estimate the presence of alternative splicing
in the genome and to propose that most, if not all, recorded
alternative variants are likely to be expressed at the protein
level in some form.
Phosphopeptide detection techniques are more 
sensitive
The comparison of the two proteomics studies showed that
the level of expression of alternatively spliced variants in the
general proteomics analysis of Brunner was less than would
be expected, but that the expression levels of alternative gene
products in the Bodenmiller experiment, which specifically
targeted and identified phosphopeptides, corresponded to
the levels of expression predicted by FlyBase. The higher pro-
portion of alternatively spliced gene products detected in the
Bodenmiller analysis is most probably related to the sensitiv-
ity of the analysis of charged phosphopeptides. One of the
effects of the sensitivity to phosphorylation sites is that the
identified peptides have a significant compositional bias. The
peptides have many fewer hydrophobic residues and mark-
edly more polar residues, suggesting that many of these phos-
phorylation sites are in regions that are disordered in
corresponding protein structures.
This observation is interesting since it may have conse-
quences for our understanding of the structural and func-
tional consequences of splicing. The detailed analysis of the
potential effects of alternative splicing in proteins shows that
alternative splicing would be expected to lead to substantial
rearrangements in the corresponding structures [11] and it is
unlikely that the large changes introduced by alternative
splicing events will generate regions that fold with a stable
hydrophobic core. It has previously been suggested that a
substantial proportion of alternative gene products are
unstructured in solution [35]. A corollary to this is that there
are only eight known pairs of alternative splice isoforms in the
Protein Data Bank (PDB) structural database [36]. In five of
these pairs the regions resulting from alternative splicing
events are disordered. It may be that many alternative splic-
ing events result in proteins that are, at least in part, unstruc-
tured and flexible in solution. If alternative splicing events are
related to disordered regions and phosphorylated residues
are more frequent in these unstructured and flexible regions,
then it follows that the disordered regions resulting from
alternative splicing events will be more easily detected by
methods that detect phosphorylated peptides. Therefore, it is
not surprising that the Bodenmiller analysis was able to
detect a higher proportion of splice isoforms.
The results of this analysis have shown that proteomics data
can indeed be used to investigate the extent of alternative
splicing at the protein level. The Bodenmiller analysis
detected peptides that differed from those in the Brunner
analysis because they specifically isolated phosphorylated
peptides from whole cell lysate, suggesting a methodology for
carrying out further experiments to detect alternative splicing
at the protein level.
Perhaps surprisingly though, our initial re-analysis of the liq-
uid chromatography tandem mass spectrometry data using
databases of predicted transcripts, translated pseudogenes
and small RNAs failed to reveal any significant new findings.
Unfortunately, while we were able to detect some evidence for
the expression of small RNAs and predicted gene models, the
number of novel identified peptides fell within the estimated
false positive rate. A complete re-analysis of the spectra might
have produced more interesting results. However, our initial
re-analysis made it clear that any proteomics study of the
expression of functional aspects of the genome would be com-
plicated by a series of logistical challenges. For example, six-
frame translations of genome transcripts would create an
enormous search space that would result in extensive and
impracticable database search times. In addition, peptide
detection sensitivity correlates with database size (especially
if most added sequences are likely not to be real peptides) and
is strongly reduced in the case of a 6-frame translated data-
base.
Nevertheless, what is and is not expressed as protein is an
interesting scientific question that needs to be addressed and
our study points the way to further experiments of this
nature. Future proteomics studies could address the question
by searching against additional databases organized for the
purpose, but specific methods to deal with the false positive
problem still need to be developed and, ideally, the detected
peptides would need to be confirmed using independent
methods.
The fact that we can show that alternative transcripts are
translated into proteins at the predicted rate is a great step
forward and shows the importance of proteomics in validat-
ing predicted transcripts. Of course, showing that the alterna-
tive splice isoforms are indeed expressed as stable proteins is
only the first step in assessing the functional role of alterna-
tive variants. In order to broaden our understanding of the
role of genomic protein diversity, further experimental
approaches are needed. We feel that these results will serve as
an important point of reference for these experiments.
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Materials and methods
Our analysis was based on the peptides detected in two pro-
teomics studies [21,22]. The first, the 'Brunner set' (for more
details, see [21]) consisted of 32,729 non-overlapping pep-
tides that could be uniquely attributed to a single gene prod-
uct from the D. melangaster proteome. In total, the
experimentally observed peptides contained sufficient infor-
mation to identify 6,980 proteins unambiguously. The sec-
ond dataset, the 'Bodenmiller set' (see [22] for more details)
contained 10,118 high-confidence phosphorylated peptides
from 3,472 gene models.
Even though the peptides detected in the two studies were
identified based on tandem mass spectrometry, there were
significant differences in the collection methods. In the Brun-
ner analysis the protein samples from which the peptides
were produced came from experiments carried out under a
wide range of distinct conditions, including 5 developmental
stages, 12 tissue types and 10 different fractionation tech-
niques. Furthermore, the coverage was further augmented by
a novel iterative data collection method [21] that resulted in a
significant increase in coverage relative to previous studies.
Cells used in the Bodenmiller analysis were from a single Dro-
sophila cell line (Kc167), but cells were grown under five dif-
ferent conditions in order to maximize phosphorylation site
identifications. Finally, phosphopeptides were isolated using
three different phosphopeptide isolation methods [37] prior
to mass spectrometric analysis using a high mass accuracy
Fourier transform ion cyclotron resonance mass spectrome-
ter in order to maximize the number of identified phos-
phopeptides.
In both studies the peptides were identified by searching
against in silico trypsin digests of the FlyBase D. melangaster
proteome. For both methods the false positive rate of peptide
identification was assessed using the statistical tool Peptide
Prophet [38] as well as a decoy database strategy and was
found to be in the low percentage range. Most tandem mass
spectra as well as their statistical analysis can be viewed in the
PhosphoPep database [39].
In order to make estimates for the expected rate of alternative
splicing, we carried out simulated peptide detection. For this
in silico peptide detection experiment the D. melangaster
proteome (dmel-all-translation-r5.4.fasta) was subject to an
in silico trypsin digest. Peptides in the in silico digest were
generated by cutting after arginine and lysine residues, except
where they were followed by proline residues. We carried out
1,000 peptide detection simulations by drawing 10,118 pep-
tides (for the Bodenmiller analysis) or 37,279 peptides (for
the Brunner set) at random from the peptides generated in
silico.
Re-analysis of the spectra
We searched 154,509 spectra from the Bodenmiller dataset
against a database that contained 903,842 peptides derived
from 17,868 translated transcripts: 10, 000 translated tran-
scripts came from predicted gene models from FlyBase, 1,456
came from the 6-frame translation of pseudogenes from Fly-
Base, 3,818 from 6-frame translations of miscellaneous func-
tional RNA (rRNA, small nuclear RNA (snRNA) and
snoRNA) from FlyBase and 2,594 were generated from the 6-
frame translation of transcripts predicted by Manak et al.
[40] to be functional.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 lists genes with
multiple isoforms detected in the Brunner and Bodenmiller
studies. Additional data file 2 provides example tandem mass
spectra of phosphopeptides distinguishing between the Sex
lethal isoforms. Additional file 3 is a table listing detected ion
masses for Sex lethal isoforms PD, PI and PL. Additional data
file 4 is a table listing detected ion masses for Sex lethal iso-
forms PC, PG, PH, PJ, PN and PO.
Additional data file 1Genes with multiple isoforms detected in the Brunner and Boden-mill r studies list of all alternative isoforms confirmed by the Brunner and Bod-enmiller nalyses.Cl ck here for file 2Example tandem mass spectra of phosphop ptides disti guishing between e S x lethal is formsPart 1A show  th  p o phopeptide GFGMSHS*LPSGMSR, which is u qu o the S x lethal is forms CG18350-PD, CG18350-PL, G18350-PI. Part 1B h ws the phosphopeptidFGMS*HSL SGMDTEFSFPSSSSR, w ic  is uniq e o the Sexletha  is f r  CG18350-PG, CG18350-PH, CG18350-PO,C, CG18350-PJ, CG18350-PN. P is he Peptide r p etscor  a d c r spond t  a <1% alse pos iv  rat . In a dition, allfr g t io ma s s are hown a d detec ed ions ar  h g lig t  i  ed.D t ct d i   for S x le h l i f rms , PI a d PLFr gm i n ass s f r t  hos p de F M-SHS*LPSGMSR, w ic  is unique t  the Sex lethal isoforms D, - L, CG18350-PI, ar s own tab laror . D ect d ions re igh ig d in r .4s s fo Sex let al i ofo ms P , PG, PH, J PN a dO  pti S*HSL GMTEFSFPS R, c  un qu to th  S x le al isofor s G H, 1 35 - O, CG18350 PC,J, N ar wn abul r fo m. Det ct d n ar  ghligh d n ed.
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